Xarelto tablets come in four strengths: 2.5 milligrams (mg), 10 mg, 15 mg, and 20 mg. The strength of Xarelto tablets you take will depend on the condition you’re trying to prevent or treat.

Xarelto tablets come in four strengths: 2.5 milligrams (mg), 10 mg, 15 mg, and 20 mg. Xarelto suspension comes in a strength of 1 mg per milliliter (mL). Typical dosages ...

If you’re taking a Xarelto 15 mg or 20 mg tablet, the dose should be taken with food right away. You can take your dose of a Xarelto 2.5 mg or 10 mg tablet with or without food.

Rivaroxaban tablets, 10 mg, 15 mg and 20 mg (RLD Xarelto) had a market value of approximately $8.052 billion per IQVIA March 2025 data. Related Topics PHARMACY ...

Rivaroxaban 2.5 mg tablets from Lupin and Taro are now considered therapeutic equivalents to name-brand rivaroxaban (Xarelto). ... the 10 mg, 15 mg, and 20 mg tablets from Lupin and Taro are under ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. ... The FDA also has given tentative approval for rivaroxaban, in dosage strengths of 10 mg, 15 mg and 20 mg.

Rivaroxaban tablets USP, 10 mg, 15 mg, and 20 mg (Xarelto) had estimated annual sales of USD 8,052 million in the US (IQVIA MAT March 2025). Lupin Limited is a global pharmaceutical leader ...

Lupin receives US FDA tentative approval for generic Xarelto tablets: Our Bureau, Mumbai Wednesday, January 24, 2024, 11:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced that it has ...

According to company’s press statement, the approval has been granted to market a generic equivalent of Xarelto Tablets, 2.5 mg, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals, Inc.

Rivaroxaban (Xarelto, Bayer) is indicated for the 'treatment of deep vein thrombosis (DVT), and prevention of recurrent DVT and pulmonary embolism (PE) following an acute DVT in adults'. For the ...

FDA Approves XARELTO® (rivaroxaban tablets) ... XARELTO® is approved for use at a 10 mg dose, once-daily for 35 days following hip replacement and for 12 days following knee replacement surgery.

Mumbai, May 15 -- The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Xarelto Tablets, 2.5 mg, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals, Inc ...